- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
DHODH Antibody 2G7 is a monoclonal antibody that recognizes dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme essential for de novo pyrimidine nucleotide biosynthesis. DHODH catalyzes the oxidation of dihydroorotate to orotate, a critical step in the production of uridine monophosphate (UMP), which supplies precursors for DNA and RNA synthesis. The enzyme is particularly important in rapidly proliferating cells and activated lymphocytes, where nucleotide requirements are elevated. This Dihydroorotate Dehydrogenase Antibody targets a protein that connects nucleotide production with mitochondrial metabolism.
The human DHODH gene is located on chromosome 16q22.2 and encodes a protein of approximately 395 amino acids with a calculated molecular weight near 43 kDa. DHODH is associated with the mitochondrial inner membrane and contains a flavin mononucleotide (FMN)-binding catalytic domain. During dihydroorotate oxidation, electrons are transferred through FMN to ubiquinone in the mitochondrial electron transport chain. This connection makes DHODH activity dependent on mitochondrial respiratory function and cellular redox balance.
De novo pyrimidine synthesis provides nucleotide precursors required for nucleic acid synthesis, membrane phospholipid production, and glycosylation reactions. DHODH represents an important regulatory point in this pathway because its activity depends on the availability of oxidized ubiquinone. Impaired mitochondrial electron transport can restrict DHODH activity and reduce pyrimidine nucleotide availability. Although pyrimidine salvage pathways can compensate under certain conditions, dependence on de novo synthesis varies with cellular metabolism and proliferative demand.
DHODH has attracted considerable interest as a therapeutic target in autoimmune disorders, inflammatory diseases, and cancer. Inhibition of this enzyme can limit pyrimidine nucleotide production and suppress the proliferation of activated lymphocytes. Leflunomide and its active metabolite teriflunomide are established DHODH inhibitors used in the treatment of autoimmune conditions. DHODH inhibition is also being investigated in oncology because some cancer cells depend heavily on de novo pyrimidine synthesis. The Dihydroorotate Dehydrogenase Antibody is relevant to research investigating metabolic vulnerabilities and nucleotide biosynthesis.
Research involving DHODH provides insight into mitochondrial function, pyrimidine metabolism, immune cell activation, and cellular proliferation. Understanding the regulation of this enzyme contributes to studies of metabolic adaptation and the coordination of nucleotide synthesis with cellular energy production. NSJ Bioreagents offers antibodies targeting metabolic enzymes for research into mitochondrial biology. A DHODH Antibody such as clone 2G7 provides a tool for examining dihydroorotate dehydrogenase expression and its role in nucleotide biosynthesis and mitochondrial metabolism.
Explore our Mitochondria Marker Antibodies collection for additional antibodies targeting mitochondrial enzymes, metabolic regulators, and proteins involved in cellular energy production.
Optimal dilution of the DHODH Antibody 2G7 / Dihydroorotate Dehydrogenase Antibody should be determined by the researcher.
N-terminal region amino acids RVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTE D from the human protein were used as the immunogen for the DHODH Antibody 2G7.
After reconstitution, the DHODH Antibody 2G7 can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Dihydroorotate Dehydrogenase antibody, Dihydroorotate Dehydrogenase 2G7 antibody, Dihydroorotate Dehydrogenase Monoclonal antibody, Dihydroorotate Oxidase antibody, DHO Dehydrogenase antibody, Mitochondrial Dihydroorotate Dehydrogenase antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.